BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 1905773)

  • 21. The diagnosis of lupus anticoagulants by the activated partial thromboplastin time--the central role of phosphatidyl serine.
    Kelsey PR; Stevenson KJ; Poller L
    Thromb Haemost; 1984 Oct; 52(2):172-5. PubMed ID: 6441303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study of "lupus-type" anticoagulant using diluted Russell's viper venom time. Study of 16 patients].
    Pardo Vigo A; Oteyza JP; Blanco L; Correa MA; César J; Avello AG; Frade JG; Navarro JL
    Sangre (Barc); 1987; 32(2):231-5. PubMed ID: 3112970
    [No Abstract]   [Full Text] [Related]  

  • 23. [Lupus-type anticoagulants and thromboses].
    Sultan Y
    Ann Med Interne (Paris); 1986; 137(6):475-6. PubMed ID: 3101565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of two simple tests for the lupus anticoagulant.
    Exner T
    Am J Clin Pathol; 1985 Feb; 83(2):215-8. PubMed ID: 3918436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The laboratory diagnosis of lupus anticoagulants.
    Lazarchick J; Kizer J
    Arch Pathol Lab Med; 1989 Feb; 113(2):177-80. PubMed ID: 2492798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical significance of lupus anticoagulant analysis in blood coagulo-fibrinolytic tests].
    Watanabe S; Harada N
    Nihon Rinsho; 1989 Dec; 48 Suppl():942-5. PubMed ID: 2516165
    [No Abstract]   [Full Text] [Related]  

  • 27. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
    Galli M; Dlott J; Norbis F; Ruggeri L; Cler L; Triplett DA; Barbui T
    Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The anticoagulant of the lupus type: a thrombotic risk factor].
    Tobelem G
    Ann Med Interne (Paris); 1987; 138(4):243-5. PubMed ID: 3115164
    [No Abstract]   [Full Text] [Related]  

  • 29. [Lupus anticoagulant in a patient with systemic lupus erythematosus complicating marked bleeding tendency].
    Onda H; Anno K; Moriyama H; Sanada M; Takai K
    Rinsho Ketsueki; 1988 Aug; 29(8):1256-62. PubMed ID: 3144617
    [No Abstract]   [Full Text] [Related]  

  • 30. [Regulation of coagulo-fibrinolytic activity and lupus anticoagulants in systemic lupus erythematosus].
    Fusegawa H; Ichikawa Y; Tanaka Y; Shiba T; Kawada T; Shimizu H; Moriuchi J; Arimori S; Ando Y
    Ryumachi; 1990 Apr; 30(2):90-8. PubMed ID: 2122531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lupus erythematosus, circulating anticoagulant and obstetric complications. Apropos of 2 cases].
    Reymond O; Stalder JB; Stalder M; The HN; Bossart H
    J Gynecol Obstet Biol Reprod (Paris); 1987; 16(2):207-11. PubMed ID: 3108357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma requirement for expression of lupus-like anticoagulant.
    Clyne LP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(6):841-4. PubMed ID: 2436999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful pregnancy in systemic lupus erythematosus with an untreated lupus anticoagulant.
    Stafford-Brady FJ; Gladman DD; Urowitz MB
    Arch Intern Med; 1988 Jul; 148(7):1647-8. PubMed ID: 3132903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody to cardiolipin, lupus anticoagulant, and fetal death.
    Lockshin MD; Qamar T; Druzin ML; Goei S
    J Rheumatol; 1987 Apr; 14(2):259-62. PubMed ID: 3110418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification and kinetic studies on a circulating anticoagulant in a suspected case of lupus erythematosus.
    Yin ET; Gaston LW
    Thromb Diath Haemorrh; 1965 Sep; 14(1-2):88-115. PubMed ID: 16955969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lupus anticoagulant].
    Huang ZL
    Zhonghua Nei Ke Za Zhi; 1988 May; 27(5):318-21. PubMed ID: 3143524
    [No Abstract]   [Full Text] [Related]  

  • 37. Central retinal-artery occlusion in a patient with circulating lupus anticoagulant.
    Reisin LH; Reisin I; Darawshi A; Aviel E
    Ann Ophthalmol; 1989 Jul; 21(7):269-71. PubMed ID: 2505658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The lupus anticoagulant.
    Moriau M; Lavenne-Pardonge E; Col-De Beys C; Lambert M; Coche E
    Ann Ital Med Int; 1986 Dec; 1(4):303-6. PubMed ID: 3152786
    [No Abstract]   [Full Text] [Related]  

  • 39. Obstetric complications associated with the lupus anticoagulant.
    Branch DW; Scott JR; Kochenour NK; Hershgold E
    N Engl J Med; 1985 Nov; 313(21):1322-6. PubMed ID: 3932854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concurrent lupus anticoagulants and prothrombin deficiency due to phenytoin use.
    Harrison RL; Alperin JB; Kumar D
    Arch Pathol Lab Med; 1987 Aug; 111(8):719-22. PubMed ID: 3115223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.